Macquarie Group
AMAG

Macquarie Group’s AMAG Pharmaceuticals AMAG Stock Holding History

Macquarie Group’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-14,725
Closed -$170K – 1983
2019
Q3 		$170K Hold
14,725
– – ﹤0.01% 1623
2019
Q2 		$147K Sell
14,725
-74,037
-83% -$799K ﹤0.01% 1643
2019
Q1 		$1.14M Sell
88,762
-442,766
-83% -$6.59M ﹤0.01% 1146
2018
Q4 		$8.07M Sell
531,528
-38,021
-7% -$724K 0.02% 642
2018
Q3 		$11.4M Buy
569,549
+52,593
+10% +$1.2M 0.02% 612
2018
Q2 		$10.1M Buy
516,956
+503,156
+3,646% +$11.1M 0.02% 637
2018
Q1 		$278K Buy
13,800
+7,200
+109% +$122K ﹤0.01% 1594
2017
Q4 		$87K Sell
6,600
-7,800
-54% -$118K ﹤0.01% 1923
2017
Q3 		$266K Buy
+14,400
New +$268K ﹤0.01% 1660

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Macquarie Group's AMAG Position: Q4 2019 in Review

Macquarie Group sold out of AMAG Pharmaceuticals (AMAG) in Q4 2019, closing a stake of 14,725 shares — an estimated $170K sold.

Macquarie Group first reported a position in AMAG in Q3 2017 and held it in 9 quarters. The position peaked at $11.4M in Q3 2018. 134 funds tracked by Wall St. Rank hold AMAG as of Q4 2019.

  • Macquarie Group reported no remaining AMAG Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Macquarie Group sold 14,725 AMAG Pharmaceuticals shares in Q4 2019, an estimated $170K.
  • Macquarie Group first reported a position in AMAG Pharmaceuticals in Q3 2017 and held it in 9 quarters.
  • Macquarie Group's AMAG Pharmaceuticals position peaked at $11.4M in Q3 2018.
  • 134 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2019.

Based on Macquarie Group's 13F filing for Q4 2019, filed 14 Feb 2020.